Oncovin is a chemotherapy drug that is better known by its generic name, vincristine. It was first approved by the US Food and Drug Administration in 1963, and it is featured in several combination chemotherapy regimens, including widely used regimens such as R-CHOP (the O is Oncovin). It works by disrupting the ability of the cancer cells to grow by dividing. It affects both cancer cells and healthy cells.
Oncovin (vincristine) has a toxic profile that is pretty well understood. It is common for people to experience some side effects in receiving this drug, but not everybody will experience side effects. For those that do, whether the side effects are serious or less serious, the patient should always tell his or her doctor about them and allow the doctor to draw conclusions as to whether the drug should be continued or not.
The following side effects are considered serious enough that, should they be experienced, it is important to notify one's doctor or health care professional as soon as possible.
The following is an incomplete list of less serious side effects associated with Oncovin. Just because they are less serious does not mean they should not be reported to one's doctor. All side effects should be reported when they occur.
To reiterate, side effects from chemotherapy are normal, but they should always be reported to your doctor or health care professional.